FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q33370925> ?p ?o ?g. }

• Q33370925 description "2006 nî lūn-bûn" @default.
• Q33370925 description "2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած" @default.
• Q33370925 description "2006 թվականի ապրիլին հրատարակված գիտական հոդված" @default.
• Q33370925 description "2006年の論文" @default.
• Q33370925 description "2006年論文" @default.
• Q33370925 description "2006年論文" @default.
• Q33370925 description "2006年論文" @default.
• Q33370925 description "2006年論文" @default.
• Q33370925 description "2006年論文" @default.
• Q33370925 description "2006年论文" @default.
• Q33370925 description "2006年论文" @default.
• Q33370925 description "2006年论文" @default.
• Q33370925 description "2006年论文" @default.
• Q33370925 description "2006年论文" @default.
• Q33370925 description "2006年论文" @default.
• Q33370925 description "2006년 논문" @default.
• Q33370925 description "article científic" @default.
• Q33370925 description "article scientific" @default.
• Q33370925 description "article scientifique (publié 2006)" @default.
• Q33370925 description "articol științific" @default.
• Q33370925 description "articolo scientifico" @default.
• Q33370925 description "artigo científico (publicado na 2006)" @default.
• Q33370925 description "artigo científico (publicado na 2006)" @default.
• Q33370925 description "artigo científico" @default.
• Q33370925 description "artikull shkencor" @default.
• Q33370925 description "artikulong pang-agham" @default.
• Q33370925 description "artykuł naukowy" @default.
• Q33370925 description "artículo científico publicado en 2006" @default.
• Q33370925 description "artículu científicu espublizáu en 2006" @default.
• Q33370925 description "bilimsel makale" @default.
• Q33370925 description "bài báo khoa học" @default.
• Q33370925 description "mokslinis straipsnis" @default.
• Q33370925 description "naučni članak" @default.
• Q33370925 description "scienca artikolo" @default.
• Q33370925 description "scientific article" @default.
• Q33370925 description "teaduslik artikkel" @default.
• Q33370925 description "tieteellinen artikkeli" @default.
• Q33370925 description "tudományos cikk" @default.
• Q33370925 description "vedecký článok" @default.
• Q33370925 description "vetenskaplig artikel" @default.
• Q33370925 description "videnskabelig artikel (udgivet 2006)" @default.
• Q33370925 description "vitenskapelig artikkel" @default.
• Q33370925 description "vitskapeleg artikkel" @default.
• Q33370925 description "vědecký článek" @default.
• Q33370925 description "wetenschappelijk artikel" @default.
• Q33370925 description "wissenschaftlicher Artikel" @default.
• Q33370925 description "επιστημονικό άρθρο" @default.
• Q33370925 description "мақолаи илмӣ" @default.
• Q33370925 description "мақолаи илмӣ" @default.
• Q33370925 description "наукова стаття, опублікована у квітні 2006" @default.
• Q33370925 description "научна статия" @default.
• Q33370925 description "научная статья" @default.
• Q33370925 description "научни чланак" @default.
• Q33370925 description "научни чланак" @default.
• Q33370925 description "מאמר מדעי" @default.
• Q33370925 description "سائنسی مضمون" @default.
• Q33370925 description "مقالة علمية" @default.
• Q33370925 description "مقالهٔ علمی" @default.
• Q33370925 description "২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q33370925 description "บทความทางวิทยาศาสตร์" @default.
• Q33370925 description "სამეცნიერო სტატია" @default.
• Q33370925 name "A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy" @default.
• Q33370925 name "A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy" @default.
• Q33370925 name "A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy" @default.
• Q33370925 type Item @default.
• Q33370925 label "A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy" @default.
• Q33370925 label "A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy" @default.
• Q33370925 label "A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy" @default.
• Q33370925 prefLabel "A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy" @default.
• Q33370925 prefLabel "A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy" @default.
• Q33370925 prefLabel "A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy" @default.
• Q33370925 P1433 Q33370925-DB647849-54FF-4CC2-A303-07DAFC7EEA38 @default.
• Q33370925 P1476 Q33370925-2940B1D1-A0D4-4E3E-8204-97230C3BEA78 @default.
• Q33370925 P2093 Q33370925-01D16B6E-E4AB-4A2A-A745-C90B4BFB5A86 @default.
• Q33370925 P2093 Q33370925-1F34F2F9-4DF2-4FFE-A4C1-151BAEA5FF3F @default.
• Q33370925 P2093 Q33370925-716287BD-C048-4B59-A0BB-E515757230C5 @default.
• Q33370925 P2093 Q33370925-8F280D96-5249-4B54-844F-47D059257AE2 @default.
• Q33370925 P2093 Q33370925-920D4AA2-E301-44E7-8E22-64802BF986C1 @default.
• Q33370925 P2093 Q33370925-94B194D4-8951-4B5A-8BDB-94F49D7B320D @default.
• Q33370925 P2093 Q33370925-A1E6CC9C-7DAF-4036-B183-08545AB17165 @default.
• Q33370925 P2093 Q33370925-BB00176A-FF67-4584-B28D-4A8478CAD4B9 @default.
• Q33370925 P2093 Q33370925-BF36C9CB-841C-425B-83CF-3A537745756F @default.
• Q33370925 P2093 Q33370925-BF567A7F-EEA9-4307-A56D-4CCAFC4087E3 @default.
• Q33370925 P2093 Q33370925-E122EC24-EF7B-43AA-AF59-74BCFE236C13 @default.
• Q33370925 P304 Q33370925-5433F9CF-C53F-41DE-8AEF-D47751C21AE5 @default.
• Q33370925 P31 Q33370925-E040992A-BB1A-4AFB-A116-2AFC2B268106 @default.
• Q33370925 P356 Q33370925-AEE7A64C-5507-4612-B4C9-ABC36299372E @default.
• Q33370925 P433 Q33370925-45CB7298-ECD0-4B6C-9498-2D77A40D1245 @default.
• Q33370925 P478 Q33370925-5FB040AA-DE18-45D9-81CA-5D3F2FCF5722 @default.
• Q33370925 P50 Q33370925-F23CBB0E-9069-4F0F-98BA-B71D2915AD37 @default.
• Q33370925 P577 Q33370925-2FC0B775-9ECF-44CA-9A51-2467399B8337 @default.
• Q33370925 P698 Q33370925-1A9988F3-8220-4117-870F-AA244B24FA58 @default.
• Q33370925 P921 Q33370925-4AA9F703-0C1C-42F3-83A5-B96DF0291072 @default.
• Q33370925 P921 Q33370925-60C24E9F-1687-402E-92E6-18B558CE44AA @default.
• Q33370925 P356 J.LUNGCAN.2006.03.004 @default.
• Q33370925 P698 16630670 @default.
• Q33370925 P1433 Q641464 @default.
• Q33370925 P1476 "A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy" @default.
• Q33370925 P2093 "E Pasquini" @default.
• Q33370925 P2093 "F Barbieri" @default.

• next